Reconstitution of Cyclin D1-Associated Kinase Activity Drives Terminally Differentiated Cells into the Cell Cycle
Open accessAbstract
Terminal cell differentiation entails definitive withdrawal from the cell cycle. Although most of the cells of an adult mammal are terminally differentiated, the molecular mechanisms preserving the postmitotic state are insufficiently understood. Terminally differentiated skeletal muscle cells, or myotubes, are a prototypic terminally differentiated system. We previously identified a mid-G(1) block preventing myotubes from progressing beyond this point in the cell cycle. In this work, we set out to define the molecular basis of such a block. It is shown here that overexpression of highly active cyclin E and cdk2 in myotubes induces phosphorylation of pRb but cannot reactivate DNA synthesis, underscoring the tightness of cell cycle control in postmitotic cells. In contrast, forced expression of cyclin D1 and wild-type or dominant-negative cdk4 in myotubes restores physiological levels of cdk4 kinase activity, allowing progression through the cell cycle. Such reactivation occurs in myotubes derived from primary, as well as established, C2C12 myoblasts and is accompanied by impairment of muscle-specific gene expression. Other terminally differentiated systems as diverse as adipocytes and nerve cells are similarly reactivated. Thus, the present results indicate that the suppression of cyclin D1-associated kinase activity is of crucial importance for the maintenance of the postmitotic state in widely divergent terminally differentiated cell types.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Under physiological conditions, the CDK4-Cyclin D1 complex is active in cycling cells and stem cells, whereas it is inactive in post-mitotic and terminally differentiated cells.
“Under physiological conditions, the CDK4–Cyclin D1 complex is active in cycling cells and stem cells, whereas it is inactive in post-mitotic and terminally differentiated cells51.”
From CDK4 inhibition diminishes p53 activation by MDM2 antagonists (2018) · cites this paper as [51]
The citation lists haven’t been fetched yet
References 56 · Cited by 94
- Authors
- Latella, L., Sacco, A., Pajalunga, D., Tiainen, M., Macera, D., D'Angelo, M., Felici, A., Sacchi, A., & Crescenzi, M.
- Affiliations
- Istituto Superiore di Sanità (IT)
- Instituto Nazionale Tumori Regina Elena (IT)
- Istituto Dermopatico dell'Immacolata (IT)
- Corresponding author
- Crescenzi, Marco
- Venue
- Molecular and Cellular Biology
- Publisher
- Informa UK Limited
- Published
- 2001-08
- Volume
- 21
- Issue
- 16
- Pages
- 5631-5643
- ISSN
- 0270-7306 (ISSN-L)
- 1098-5549
- PMC
- PMC87284
- OpenAlex
- W2161667673
- Cited by
- 94
- References
- 56
- Citations by year
- 2025: 3 · 2024: 3 · 2022: 2 · 2021: 4 · 2019: 1 · 2018: 6 · 2017: 4 · 2016: 3 · 2015: 4 · 2014: 5 · 2013: 3 · 2012: 8
- FWCI
- 3.97
- Type
- journal article
- Language
- en
- Open access
- green
- europepmc.org
- Locations
- Molecular and Cellular Biology (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Fondazione Telethon
- Fondazione Italiana per la Ricerca sul Cancro
- Topics
- Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Muscle Physiology and Disorders
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Genomics and Chromatin Dynamics
- Keywords
- cyclin D1, CDK4, terminal differentiation, myotubes, cell cycle re-entry, retinoblastoma protein phosphorylation, cyclin E, CDK2, muscle-specific gene expression, adipocytes, neurons, C2C12 myoblasts
- MeSH terms
- Animals, Cell Cycle, Cell Differentiation, Cell Line, Proto-Oncogene Proteins, Signal Transduction, Cyclin-Dependent Kinases, Cyclin D1, Cyclin-Dependent Kinase 4, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review